Falduto et al 1998 New isolated human matrix metalloprotease gene. Derwent Acc# AAV08170 from WO9840475 alignment with SEQ ID No: 6.* |
Falduto et al 2002 (filing date Mar. 1997) Human matrix metalloprotease gene, proteins encoded therefrm and methods of using same. SEQ ID No.: 1 of US6399371 alignment with SEQ ID No.: 6.* |
Birren et al, 1998 Homo sapiens chromosome 17, clone hRPC.161_P_9. EMBL Acc# AC006237 alignment with SEQ ID No.: 3.* |
Ausubel, 1998 Current Protocols in Molecular Biology Chapters 1, 9, 13, and 16 and Appendix 5. John Wiley & Sons, Inc. New York, NY.* |
Lohi et al, 2001 EMBL Acc# AF219624. Alignment with SID 6.* |
Ausubel, F.M., (ed.) Current Protocols in Molecular Biology, Wiley and Sons, New York, vol. 8, 1988. |
Berger, S.B. and A.R. Kimmel, (eds.) Guide to Molecular Cloning Techniques, Methods in Enzymology Academic Press, San Diego, 1987, pp. 49-54, 215-219 and 227-234. |
Eisenthal, R. and M.J. Danson, (eds.), Enzyme Assays: A Practical Approach, Oxford University Press, 1992, pp. 1-376. |
Shapiro, S.D., et al., “Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages,” J. Biol. Chem., 1993, 268(32), 23824-23829 (XP00056434 and XP-002203714). |
Strausberg, R., “Matrix metallopteinase-14,” Database EMBL Online, Mar. 7, 2000, Accession No. AW519125, 1 page (XP-002203713). |
PCT International Search Report dated Jul. 16, 2002 (PCT/US01/16563). |
Yang, M., et al., “Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts,” J. Biological Chemistry, 1998, 273(28), 17893-17900. |
Yoshiyama, Y., et al., “Selective distribution of matrix metalloproteinase-3 (MMP-3) in alzheimer's disease brain,” Acta Meirp[atjip];, 2000, 99, 91-95. |
Invitation to Pay Additional Fees with Partial Search Report dated April 2, 2002 (PCT/US01/16563). |
Akane et al., “Direct Dideoxy Sequencing of Genomic DNA by Ligation-Mediated PCR”, Biotechniques, 1994, vol. 16, pp. 238-241. |
Altschul et al., “Basic Local Alignment Search Tool,” J. Mol. Biol., 1990, 215, 403-410. |
American Veterinary Medical Associaton, Report of the American Veterinary Medical Assoc., Panel on Euthanasia, Journal of American Veterinary Medical Assoc., 1993, 202, 229-249. |
Anderson, “Human Gene Therapy”, Nature, 1998, Suppl. To vol. 392, No. 3379, pp. 25-30. |
Anderson, W. F., “Human gene therapy,” Science, 1992, 256, 808-813. |
Aujame et al., “High Affinity Human Antibodies by Phage Display”, Human Antibodies, 1997, vol. 8, No. 4, pp. 155-168. |
Ausubel, et al. (Eds.), “Chapter 6, Screening of recombinant DNA libraries,” Current Protocols in Molecular Biology, 1994, John Wiley & Sons, 6.0.1-6.4.10. |
Baindur et al., “Selective fluorescent ligands for pharmacological receptors,” Drug Dev. Res., 1994, 33, 373-398. |
Baker et al., “Induction of Acetylcholine Receptor Clustering by Native Polystyrene Beads. Implication of an Endogenous Muscle-derived Signalling System”, J. Cell Sci., 1992, vol. 102, pp. 543-555. |
Benoist et al., “In vivo sequence requirements of the SV40 early promoter region,” Nature, 1981, 290, 304-310. |
Bertilsson, G. et al., “Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction”, Proc. Natl. Acad. Sci. USA, 1998, 95, 12208-12213. |
Bossé, R., et al., “Development of nonseparation binding and functional assays for G protein-coupled receptors for high throughput screening: Pharmacological characterization of the immobilized CCR5 receptor on FlashPlate®,” J. Biomolecular Screening, 1998, 3(4), 285-292. |
Bruggemann, M., et al., “Production of human antibody repertoires in transgenic mice,” Curr. Opin. Biotechnol., 1997, 8, 455-458. |
Bruggemann, M., et al., “Strategies for expressing human antibody repertoires in transgenic mice,” Immunol. Today, 1996, 17(8), 391-397. |
Cane, D. E., et al., “Harnessing the Biosynthetic Code: Combinations, Permutations, and Mutations,” Science, Oct. 1998, 282, 63-68. |
Capecchi, M. R., “Altering the genome by homologous recombination,” Science, 1989, 244, 1288-1292. |
Cheng, L. et al., “Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo”, Circulation, 1998, 98, 2195-2201. |
Choo, Y., et al., “Promoter-specific activation of gene expression directed by bacteriophage-selected zinc fingers,” J. Mol. Biol., 1997, 273, 525-532. |
Cosman, D., et al., “High Level Stable Expression of Human Interleukin-2 receptors in Mouse Cells Generates only Low Affinity Interleukin-2 Binding Sites,” Mol. Immunol., 1986, 23(9), 935-941. |
Cosman, D., et al., “Cloning, sequence and expression of human interleukin-2, receptor,” Nature, 1984, 312, 768-771. |
Dayoff, in Atlas of Protein Sequence and Structure, 1972, National Biochemical Research Foundation, Washington, D.C., 5, 124. |
Deckert, T. et al., “Implications for micro-and macrovascular disease”, Diabetes Care, 1992, 15(9), 1181-1191. |
Douglas, A. M., et al., “Direct sequencing of double-stranded PCR products incorporating a chemiluminescent detection procedure,” Biotechniques, 1993, 14, 824-828. |
Drmanac, R., et al., “DNA Sequence Determination by Hybridization A Strategy for Efficient Large-Scale Sequencing,” Science, Jun. 1993, 260, 1649-1652. |
Drmanac, S., et al., “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,” Nature Biotechnology, 1998, 16, 54-58. |
Ebihara, I., et al., “Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus”, Am. J. Kidney Dis., 1998, 32(4), 544-550. |
Falk, E. et al., “Coronary plaque disruption”, Circulation, 1995, 92, 657-671. |
Fields, S., et al., “A novel genetic system to detect protein-protein interactions,” Nature, 1989, 340, 245-246. |
Fields, S., et al., “The two-hybrid system: an assay for protein-protein interactions,” Trends in Genetics, 1994, 10, 286-292. |
Fischer, S. G., et al., “DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory,” Proc. Natl. Acad. Sci. USA, 1983, 80, 1579-1583. |
Foote, J., et al., Antibody framework residues affecting the conformation of the hypervariable loops, J. Mol. Biol., 1992, 224, 487-499. |
Forough, R. et al., “Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo”, Cir. Res., 1996, 79(4), 812-820. |
Frank, K. et al., “Diabetic eye disease: A primary care perspective”, South. Med. J., 1996, 89(5), 463-470. |
Friedmann, T., “Progress toward human gene therapy,” Science, 1989, 244, 1275-1281. |
Fuster, V. et al., “Acute coronary syndromes: biology”, Lancet, 1999, 353(suppl. II), 5-9. |
Gerhardt, C. C., et al., “Functional characteristics of heterologously expressed 5-HT receptors,” Eur. J. Pharmacology, 1997, 334, 1-23. |
Gomez, D. et al., “Tissue inhibitors of metalloproteinases: structure, regulation and biological functions”, Eur. J. Cell. Biol., 1997, 74, 111-122. |
Greisman, H. A., et al., “A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites,” Science, 1997, 275, 657-661. |
Harendza, S. et al., “In vitro characterization of the mesangial phenotype in a proliferative glomerulonephritis of the rat”, Nephrol. Dial. Transplant, 1997, 12, 2537-2541. |
Henikoff, S., et al., “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci. USA, 1992, 89, 10915-10919. |
Hill, D. C., “Trends in development of high-throughput screening technologies for rapid discovery of novel drugs,” Cur. Opinion Drug Disc. Dev., 1998, 1(1), 92-97. |
Hoogenboom H. R., “Designing and optimizing library selection strategies for generating high-affinity antibodies,” TIBTECH, 1997, 15, 62-70. |
Jampol, L. et al., “Peripheral proliferative Retinopathies”, Surv. Ophthalmol., 1980, 25(1), 1-14. |
Jayawickreme, C. K., et al., Gene expression systems in the development of high-throughput screens, Current Opinion in Biotechnology, 1997, 8, 629-634. |
Jones, P. T., et al., “Replacing the compementarity-determining regions in a human antibody with those from a mouse,” Nature, 1986, 321, 522-525. |
Karlin, S., et al., “Applications and statistics for multiple high-scoring segments in molecular sequences,” Proc. Natl. Acad. Sci. USA, 1993, 90, 5873-5787. |
Kettleborough, C. A., et al., “Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation,” Protein Engin., 1991, 4(7), 773-783. |
Kieleczawa, J., et al., “DNA sequencing by primer walking with strings of contiguous hexamers,” Science, 1992, 258, 1787-1791. |
Kim, J., et al., “Design of TATA box-binding protein/zinc finger fusions for targeted regulation of gene expression,” Proc. Natl. Acad. Sci. USA, 1997, 94, 3616-3620. |
Kosano, H. et al., “ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy”, Life Sciences, 1999, 64(25), 2307-2315. |
Lehninger, “Chapter 4, The amino acid building blocks of proteins,” Biochemistry, 2nd Ed., 1975, Worth Publishers, Inc., New York, New York, 71-77. |
Lin, A. H., et al., “The oxazolidinone epererzolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin,” Antimicrobial Agents and Chemotherapy, 1997, 41(10), 2127-2131. |
Lindstedt, L. et al., “Matrix metalloproteinases-3, -7 and -12, but not -9, reduce high intensity lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I”, J. Biol. Chem., 1999, 274(32), 22627-22634. |
Liu, Q., et al., “Design of polydactyl zinc-finger proteins for unique addressing within complex genomes,” Proc. Natl. Acad. Sci. USA, 1997, 94, 5525-5530. |
Luckow, V. A., et al., “High Level Expression of Nonfused Foreign Genes with Autographa californica Nuclear Polyhedrosis Virus Expression Vectors,” Virology, 1989, 170, 31-39. |
Luckow, V. A., et al., “Trends in the development of baculovirus expression vectors,” Bio/Technology, 1988, 6, 47-55. |
Makishima, M. et al., “Identification of a nuclear receptor for bile acids”, Science, 1999, 284, 1362-1365. |
Maxam, A. M., et al., “Sequencing end-labeled DNA with bse-secific chemical cleavages”, Meth. Enzymol., 1977, vol. 65, 499-560. |
McColl, D. J., et al., “Structure-based design of an RNA-binding zinc finger”, Proc. Natl. Acad. Sci. (USA), 1997, vol. 96, 9521-9526. |
Miller, A. D., “Human gene therapy comes of age”, Nature, 1992, vol. 357, pp. 455-460. |
Mirzabekov, A. D., “DNA sequencing by hybridization—A megasequencing method and a diagnostic tool?”, TIBTECH, 1994, vol. 12, 27-32. |
Morrison, et al., “Genetically engineered antibody molecules,” Dixon, F.J., et al. (Eds.), Adv. Immunol., 1989, 44, 65-92. |
Myers, R. M., et al., “Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA: DNA duplexes”, Science, 1985, vol. 230,1242-1246. |
Myers, P., “Will combinatorial chemistry deliver real medicines,” Curr. Opin. Biotechnology, 1997, 8, 701-707. |
Nagase, H. et al., “Matrix metalloproteinases”, J. Biol. Chem., 1999, 274(31), 21491-21494. |
Nakayama, G. R., “Microplate assays for high-throughput screening,” Cur. Opinion Drug Disc. Dev., 1998, 1, 85-91. |
Newby, A.C. et al., “Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis”, Basic Res. Cardiol., 1994, 89(suppl. 1), 59-70. |
Okayama, H., et al., “A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells,” Mol. Cell. Biol., 3(2), 280-289. |
Orita, M., et al., “Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms,” Proc. Natl. Acad. Sci. USA, 1989, 86, 2766-2770. |
Padlan, E. A., “A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties,” Molecular Immunol., 1991, 28(4/5), 489-498. |
Parks, D. et al., “Bile acids: Natural ligands for an orphan nuclear receptor”, Science, 1999, 284, 1365-1368. |
Pastinen, T., et al., “Minisequencing: A specific tool for DNA analysis and diagnostics on oligonucleotide arrays,” Genome Res., 1997, 7, 606-614. |
Pausch, M. H., “G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery,” Trends in Biotechnology, 1997, 15, 487-494. |
Pease, A. C., et al., “Light-generated oligonucleotide arrays for rapid DNA sequence analysis,” Proc. Natl. Acad. Sci. USA, 1994, 91, 5022-5026. |
Phillips, S. D., et al., “Quino[1,2-c]quinazolines. I. Synthesis of quino[1,2-c]quinazolinium derivatives and the related indazolo[2,3-a]quinoline derivatives as analogs of the antitumor benzol[c]phenanthridine alkaloids,” J. Heterocyclic Chem., 1980, 17(19), 1489-1596. |
Pillemer, G., et al., “Insulin dependence of murine lymphoid T-cell leukemia,” Int. J. Cancer, 1992, 50, 80-85. |
Pindon, A., et al., “Thrombin-induced reversal if astricyte stellation is mediated by activation of protein kinase C β-1,” Eur. J. Biochem., 1998, 255, 766-774. |
Posner, I., et al., “Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis,” Molecular Pharmacology, 1993, 45, 673-683. |
Pulver, A. E., et al., “The Johns Hopkins University Collaborative Schizophrenia Study: An Epidemiologic-Genetic Approach to Test the Heterogeneity Hypothesis and Identify Schizophrenia Susceptibility Gene,” Cold Spring Harbor Symposia on Quantitative Biology, ©1996, 61, 797-814. |
Qu et al., “A Role for melanin-concentrating hormone in the central regulation of feeding behaviour”, Nature, 1996, 380, 243-247. |
Rader, C., et al., “Phage display of combinationial antibody libraries,” Curr. Opin. Biotechnol., 1997, 8, 503-508. |
Ramsay, G., “DNA chips: state-of-the-art,” Nature Biotechnology, 1999, 16, 40-48. |
Reece, P. A., et al., “Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer,” Cancer Research, 1987, 47(11), 2996-2999. |
Reinsheid, R. K., et al., “Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor,” Science, 1995, 270, 792-794. |
Rendu, F., et al., “Inhibition of platelet activation by tyrosine kinase inhibitors,” Biol. Pharmacology, 1992, 44(5), 881-888. |
Riechmann, L., et al., “Reshaping human antibodies for therapy,” Nature, 1988, 332, 323-327. |
Riesner, D., et al., “Temperature-gradient gel electrophoresis of nucleic acids: Analysis of conformational transitions, sequence variations, and protein-nucleic acid interactions,” Electrophoresis, 1989, 10, 377-389. |
Roberts, E., et al., “Potassium permanganate and tetraethylammonium chloride are a safe and effective substitute for osmium tetroxide in solid-phase fluorescent chemical cleavage of mismatch,” Nucl. Acids Res., 1997, 25(16), 3377-3378. |
Rogers, M. V., “Light on high-throughput screening: fluorescence-based assay technologies,” Drug Discovery Today, 1997, 2(4), 156-160. |
Rossi, M. et al., “Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on Body Weight”, Edocrinology, 1997, 138(1), 351-355. |
Rowley, G., et al., “Ultrarapid mutation detection by multiplex solid-phase chemical cleavage,” Genomics, 1995, 30, 574-582. |
Saito, Y., et al., “Molecular characterization of the melanin-concentrating-hormone receptor,” Nature, 1999, 400, 265-269. |
Sakurai, T., et al., “Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior,” Cell, 1998, 92, 573-585. |
Sanger, F., et al., “DNA sequencing with chain-terminating inhibitors,” Proc. Natl. Acad. Sci. USA, 1977, 74(12), 5463-5467. |
Sauro, M. D., et al., “Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s),” J. Pharm. And Experimental Therapeutics, 1993, 267(3), 1119-1125. |
Schafer, A. J., et al., “DNA variations and the future of human genetics,” Nature Biotechnology, 1998, 16, 33-39. |
Schroeder, K. S., et al., “FLIPR: A new instrument of accurate, high throughput optical screening,” J. Biolmolecular Screening, 1996, 1, 75-80. |
Sculier, J. P., et al., “Role of an intensive care unit (ICU) in a medical oncology department,” No. 257, Cancer Immunol. And Immunother., 1986, 23, A65. |
Segal, D. J., et al., “Toward controlling gene expression at will: Selection and design of zine finger domains recognizing each of the 5′-GNN-3′ DNA target sequences,” Proc. Natl. Acad. Sci. USA, 1999, 96, 2758-2763. |
Shaw, S. H., et al., “A Genome-Wide Search for Schizophrenia Susceptibility Genes,” Amer. J. of Med. Genet. (Neuropsych. Genet.), 1998, 81, 364-376. |
Shimada et al,. “Mice lacking melanin-concentrating hormone are hypophagic and lean”, Nature, 1998, 396, 670-673. |
Shumaker, J. M., et al., “Mutation detection by solid phase primer extension,” Hum. Mutat., 1996, 7, 346-354. |
Sikora, E., et al., “Quinazoline CB 3717 and CB 3703 inhibition of folate retention and metabolism in ehrlich ascites carcinoma cells and some organs of the host-mouse,” Cancer Letters, 1984, 23, 289-295. |
Sikora, E., et al., “Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cells,” Analytical Biochemistry, 1988, 172, 344-355. |
Sim, L. J., et al., “Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTPγS binding in rat brain,” Neuroreport, 1996, 7, 729-733. |
Smith, T. F., et al., “Comparison of biosequences,” Adv. Appl. Math., 1981, 2, 482-489. |
Smith-Swintosky, V. L., et al., “protease-activated receptor-2 (PAR-2— is present in the rat hippocampus and is associated with neurodegeneration,” J. Neurocham, 1997, 69, 1890-1896. |
Sonnhammer, E., et al., “A hidden markov model for predicting transmembrane helices in protein sequences,” Glasgow, J., et al. (Eds.), ISMB, 1998, 6, 175-182. |
Stables, J., et al., “A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor,” Analytical Biochemistry, 1997, 252, 115-126. |
Steen, B. et al., “Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes”, Invest. Ophthalmol. Vis. Sci., 1998, 39(11), 2194-2200. |
Stratowa, C., et al., “Use of a luciferase reporter system for characterizing G-protein-linked receptors,” Current Opinion in Biotechnology, 1995, 6, 574-581. |
Steinmann-Niggli, K. et al., “Rat mesangial cells and matrix metalloproteinase inhibitor: Inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation”, J. Am Soc. Nephrol., 1997, 8, 395-405. |
Strosberg, et al., “Functional expression of receptors in microorganisms,” Trends in Pharmacological Sciences, 1992, 13, 95-98. |
Strosberg, A. D., et al., “Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins,,” Eur. J. Biochem., 1991, 196, 1-10. |
Suidan, H. A., et al., “The thrombin receptor in the nervous system,” Semin Thromb Hemost, 1996, 22(2), 125-133. |
Summers, et al., A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures, Texas Agricultural Experimental Station Bulletin No. 1555, 1987, 2-46. |
Sutherland, E. W., et al., “Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP),” Circulation, 1968, 37, 279-306. |
Sweetnam, P. M., et al., “The role of receptor binding in drug discovery,” J. Natural Products, 1993, 56(4), 441-455. |
Tempest, P. R., et al., “Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo,” Bio/Technology, 1991, 9,266-271. |
Trejo, J., et al., “The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts,” J. Biol. Chem., 1996, 271, 21536-21541. |
Turgeon, V. L., et al., “Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation,” J. Neurosci, 1998, 18(17), 6882-6891. |
Ubl, J. J., et al., “Characteristics of thrombin-induced calcium signals in rat astrocytes,” Glia, 1997, 21, 361-369. |
Vanden Broeck, “G-protein-coupled receptors in insect cells”, Int. Rev. Cytology, 1996, 164, 189-268. |
Verhoeyen, M., et al., “reshaping human antibodies: Grafting an antilysozyme activity,” Science, 1988, 239, 1534-1536. |
Verma, I. M., “Gene therapy,” Scientific American, 1990, 68-84 (pp. 73-80 and 83 are advertisements). |
Walder, R. Y., et al., “Oligodeoxynucleotide-directed mutagenesis using the yeast transformation system,” Gene, 1986, 42, 133-139. |
White, M. B., et al., “Detecting single base substitutions as heteroduplex polymorphisms,” Genomics, 1992, 12, 301-306. |
Whiteford, H. A., et al., “Mianserin-Induced Up-Regulation of Serotonin Receptors on Normal Human Platelets in Vivo,” Life Sciences, 1993, 53(4), 371-376. |
Wieboldt, R., et al., “Immunoaffinity ultrafiltration with ion spray HPLC/MS for screening small-molecule libraries,” Anal. Chem., 1997, 69(9), 1683-1691. |
Williams, M., “Receptor binding in the drug discovery process,” Medicinal Research Reviews, 1991, 11(2), 147-184. |
Wolbring, G., et al., “Inhibition of GTP-utilizing enzymes by tyrphostins,” J. Biol. Chem., 1994, 269(36), 22470-22472. |
Wu, H., et al., “Building zinc fingers by selection: toward a therapeutic application,” Proc. Natl. Acad. Sci. USA, 1995, 92, 344-348. |
Yoneda, T., et al., “The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice,” Cancer Research, 1991, 51, 4430-4435. |
Young, E., et al., “Isolation and characterization of a New Cellular Oncogene Encoding a Protein with Multiple Potential Transmembrane Domains,” Cell, 1986, 45, 711-719. |
Zempo, N. et al., “Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor”, Artherioscler. Thromb. Vasc. Biol., 1996, 16(1), 28-33. |
Zeng, Z., et al. “Cloning of a Putative Human Neurotransmitter Receptor Expression in Skeletal Muscle and Brain,” Biochem. & Biophys. Resear. Commun., 1998, 242, 575-578 (Article No. RC977591). |
Harlow, E. et al., in Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988, Chapter 6. |
Hendrix, R. W. (ed.), Lambda II, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1980. |
Hershey, A. D. (ed.), The Bacteriophage Lambda, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1973. |
Kruse et al. (eds.), in Tissue Culture, Academic Press, 1973. |
O'Rielly et al. (eds.), in Baculovirus Expression Vectors: A Laboratory Manual, W.H. Freeman and Company, New York, 1992. |
Osol, A (ed.), in Remington's Pharmaceutical Sciences, 16th edition, 1980. |
Sambrook et al., in Molecular Cloning: A Laboratory Manual, second edition, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1989. |
Summers et al., A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures, Texas Agricultural Experimental Station Bulletin No. 1555, 1987. |